<!DOCTYPE html>
<html>
<head>
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
<meta charset="utf-8" />
</head>

<body style="margin: 0;">

<div id="p214" style="overflow: hidden; position: relative; background-color: white; width: 1210px; height: 935px;">
<style class="shared-css" type="text/css" >
.t {
	transform-origin: bottom left;
	z-index: 2;
	position: absolute;
	white-space: pre;
	overflow: visible;
	line-height: 1.5;
}
.text-container {
	white-space: pre;
}
@supports (-webkit-touch-callout: none) {
	.text-container {
		white-space: normal;
	}
}
</style>
<style type="text/css" >

#t1_214{left:35px;bottom:24px;letter-spacing:-0.34px;word-spacing:0.13px;}
#t2_214{left:306px;bottom:30px;}
#t3_214{left:313px;bottom:24px;letter-spacing:0.16px;}
#t4_214{left:346px;bottom:30px;}
#t5_214{left:351px;bottom:24px;letter-spacing:-0.16px;word-spacing:-0.22px;}
#t6_214{left:517px;bottom:30px;}
#t7_214{left:524px;bottom:24px;letter-spacing:-0.28px;word-spacing:-0.09px;}
#t8_214{left:288px;bottom:860px;letter-spacing:0.11px;word-spacing:-0.55px;}
#t9_214{left:288px;bottom:829px;letter-spacing:0.27px;word-spacing:-0.69px;}
#ta_214{left:1115px;bottom:27px;letter-spacing:0.23px;}
#tb_214{left:35px;bottom:777px;letter-spacing:0.02px;word-spacing:0.17px;}
#tc_214{left:35px;bottom:759px;letter-spacing:0.06px;word-spacing:0.13px;}
#td_214{left:35px;bottom:739px;letter-spacing:0.16px;}
#te_214{left:396px;bottom:739px;}
#tf_214{left:35px;bottom:702px;letter-spacing:0.03px;word-spacing:0.15px;}
#tg_214{left:35px;bottom:683px;letter-spacing:0.06px;word-spacing:-0.8px;}
#th_214{left:35px;bottom:665px;letter-spacing:0.07px;word-spacing:0.11px;}
#ti_214{left:35px;bottom:645px;letter-spacing:0.16px;}
#tj_214{left:386px;bottom:645px;}
#tk_214{left:35px;bottom:608px;letter-spacing:0.18px;word-spacing:0.01px;}
#tl_214{left:35px;bottom:589px;letter-spacing:0.05px;word-spacing:0.13px;}
#tm_214{left:35px;bottom:570px;letter-spacing:0.15px;word-spacing:0.04px;}
#tn_214{left:35px;bottom:551px;letter-spacing:0.09px;word-spacing:0.09px;}
#to_214{left:35px;bottom:531px;letter-spacing:0.16px;}
#tp_214{left:386px;bottom:531px;}
#tq_214{left:35px;bottom:495px;letter-spacing:0.12px;word-spacing:0.06px;}
#tr_214{left:35px;bottom:476px;letter-spacing:0.04px;word-spacing:0.14px;}
#ts_214{left:35px;bottom:457px;letter-spacing:0.15px;word-spacing:0.04px;}
#tt_214{left:35px;bottom:437px;letter-spacing:0.16px;}
#tu_214{left:386px;bottom:437px;}
#tv_214{left:35px;bottom:401px;letter-spacing:0.06px;word-spacing:0.13px;}
#tw_214{left:35px;bottom:382px;letter-spacing:0.12px;word-spacing:0.06px;}
#tx_214{left:35px;bottom:363px;letter-spacing:0.12px;word-spacing:0.07px;}
#ty_214{left:35px;bottom:343px;letter-spacing:0.13px;word-spacing:0.05px;}
#tz_214{left:35px;bottom:324px;letter-spacing:0.08px;word-spacing:0.1px;}
#t10_214{left:35px;bottom:304px;letter-spacing:0.16px;}
#t11_214{left:386px;bottom:304px;}
#t12_214{left:35px;bottom:269px;letter-spacing:0.05px;word-spacing:0.14px;}
#t13_214{left:35px;bottom:249px;letter-spacing:0.13px;word-spacing:0.06px;}
#t14_214{left:35px;bottom:229px;letter-spacing:0.05px;word-spacing:-1.1px;}
#t15_214{left:35px;bottom:210px;letter-spacing:0.04px;word-spacing:0.15px;}
#t16_214{left:35px;bottom:190px;letter-spacing:0.02px;word-spacing:0.17px;}
#t17_214{left:35px;bottom:171px;letter-spacing:0.16px;}
#t18_214{left:396px;bottom:171px;}
#t19_214{left:35px;bottom:135px;letter-spacing:0.12px;word-spacing:0.07px;}
#t1a_214{left:35px;bottom:116px;letter-spacing:-0.02px;word-spacing:0.21px;}
#t1b_214{left:35px;bottom:96px;letter-spacing:0.08px;word-spacing:0.1px;}
#t1c_214{left:35px;bottom:77px;letter-spacing:0.16px;}
#t1d_214{left:396px;bottom:77px;}
#t1e_214{left:618px;bottom:777px;letter-spacing:0.03px;word-spacing:0.15px;}
#t1f_214{left:618px;bottom:759px;letter-spacing:0.04px;word-spacing:0.15px;}
#t1g_214{left:618px;bottom:739px;letter-spacing:0.05px;word-spacing:0.14px;}
#t1h_214{left:618px;bottom:720px;letter-spacing:0.16px;}
#t1i_214{left:979px;bottom:720px;}
#t1j_214{left:618px;bottom:683px;letter-spacing:0.07px;word-spacing:0.12px;}
#t1k_214{left:618px;bottom:665px;letter-spacing:0.05px;word-spacing:0.14px;}
#t1l_214{left:618px;bottom:645px;letter-spacing:0.05px;word-spacing:0.13px;}
#t1m_214{left:618px;bottom:625px;letter-spacing:0.16px;}
#t1n_214{left:988px;bottom:625px;}
#t1o_214{left:618px;bottom:589px;letter-spacing:0.08px;word-spacing:0.11px;}
#t1p_214{left:618px;bottom:570px;letter-spacing:0.02px;word-spacing:-1.07px;}
#t1q_214{left:618px;bottom:551px;letter-spacing:0.11px;word-spacing:0.08px;}
#t1r_214{left:618px;bottom:531px;letter-spacing:0.05px;word-spacing:0.14px;}
#t1s_214{left:618px;bottom:512px;letter-spacing:0.08px;word-spacing:0.1px;}
#t1t_214{left:618px;bottom:492px;letter-spacing:0.13px;word-spacing:-0.72px;}
#t1u_214{left:618px;bottom:473px;letter-spacing:-0.07px;word-spacing:0.25px;}
#t1v_214{left:763px;bottom:473px;letter-spacing:0.16px;}
#t1w_214{left:1123px;bottom:473px;}
#t1x_214{left:618px;bottom:437px;letter-spacing:-0.01px;word-spacing:0.2px;}
#t1y_214{left:618px;bottom:418px;letter-spacing:0.07px;word-spacing:0.12px;}
#t1z_214{left:618px;bottom:398px;letter-spacing:0.06px;word-spacing:-0.22px;}
#t20_214{left:618px;bottom:379px;letter-spacing:0.08px;word-spacing:0.11px;}
#t21_214{left:618px;bottom:359px;letter-spacing:-0.23px;word-spacing:1.63px;}
#t22_214{left:715px;bottom:359px;letter-spacing:0.16px;}
#t23_214{left:1076px;bottom:359px;}
#t24_214{left:618px;bottom:324px;letter-spacing:0.08px;word-spacing:-1.01px;}
#t25_214{left:618px;bottom:304px;letter-spacing:0.1px;word-spacing:0.08px;}
#t26_214{left:618px;bottom:284px;letter-spacing:0.1px;word-spacing:0.08px;}
#t27_214{left:618px;bottom:266px;letter-spacing:0.05px;word-spacing:0.14px;}
#t28_214{left:618px;bottom:247px;letter-spacing:0.03px;word-spacing:0.36px;}
#t29_214{left:618px;bottom:227px;letter-spacing:0.16px;}
#t2a_214{left:979px;bottom:227px;}
#t2b_214{left:618px;bottom:190px;letter-spacing:0.11px;word-spacing:0.07px;}
#t2c_214{left:618px;bottom:172px;letter-spacing:0.14px;word-spacing:0.05px;}
#t2d_214{left:618px;bottom:152px;letter-spacing:0.09px;word-spacing:-0.31px;}
#t2e_214{left:618px;bottom:133px;letter-spacing:0.14px;word-spacing:0.05px;}
#t2f_214{left:618px;bottom:113px;letter-spacing:0.04px;word-spacing:-0.07px;}
#t2g_214{left:618px;bottom:94px;letter-spacing:0.16px;}
#t2h_214{left:988px;bottom:94px;}
#t2i_214{left:23px;bottom:915px;letter-spacing:-0.14px;}

.s0_214{font-size:10px;font-family:ArialMT_5tg;color:#000;}
.s1_214{font-size:6px;font-family:ArialMT_5tg;color:#000;}
.s2_214{font-size:28px;font-family:Arial-BoldMT_5te;color:#000;}
.s3_214{font-size:17px;font-family:Arial-BoldMT_5te;color:#000;}
.s4_214{font-size:17px;font-family:ArialMT_5tg;color:#000;}
.s5_214{font-size:17px;font-family:ArialMT_5tg;color:#005B99;}
.s6_214{font-size:11px;font-family:Helvetica, Arial, sans-serif;color:#000;}
</style>
<style id="fonts214" type="text/css" >

@font-face {
	font-family: Arial-BoldMT_5te;
	src: url("fonts/Arial-BoldMT_5te.woff") format("woff");
}

@font-face {
	font-family: ArialMT_5tg;
	src: url("fonts/ArialMT_5tg.woff") format("woff");
}

</style>
<div id="pg214Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg214" style="-webkit-user-select: none;"><object width="1210" height="935" data="214/214.svg" type="image/svg+xml" id="pdf214" style="width:1210px; height:935px; z-index: 0;"></object></div>
<div class="text-container"><span id="t1_214" class="t s0_214">Version 4.2024 © 2024 National Comprehensive Cancer Network </span>
<span id="t2_214" class="t s1_214">© </span>
<span id="t3_214" class="t s0_214">(NCCN </span>
<span id="t4_214" class="t s1_214">© </span>
<span id="t5_214" class="t s0_214">), All rights reserved. NCCN Guidelines </span>
<span id="t6_214" class="t s1_214">® </span>
<span id="t7_214" class="t s0_214">and this illustration may not be reproduced in any form without the express written permission of NCCN. </span>
<span id="t8_214" class="t s2_214">NCCN Guidelines Version 4.2024 </span>
<span id="t9_214" class="t s2_214">Head and Neck Cancers </span>
<span id="ta_214" class="t s3_214">MS-73 </span>
<span id="tb_214" class="t s4_214">radiation fraction size and overall treatment time. Int J Radiat Oncol Biol </span>
<span id="tc_214" class="t s4_214">Phys 2006;64:77-82. Available at: </span>
<span id="td_214" class="t s5_214">http://www.ncbi.nlm.nih.gov/pubmed/16169681</span><span id="te_214" class="t s4_214">. </span>
<span id="tf_214" class="t s4_214">165. Yu E, Shenouda G, Beaudet MP, Black MJ. Impact of radiation </span>
<span id="tg_214" class="t s4_214">therapy fraction size on local control of early glottic carcinoma. Int J Radiat </span>
<span id="th_214" class="t s4_214">Oncol Biol Phys 1997;37:587-591. Available at: </span>
<span id="ti_214" class="t s5_214">http://www.ncbi.nlm.nih.gov/pubmed/9112457</span><span id="tj_214" class="t s4_214">. </span>
<span id="tk_214" class="t s4_214">166. Horiot JC, Le Fur R, N'Guyen T, et al. Hyperfractionation versus </span>
<span id="tl_214" class="t s4_214">conventional fractionation in oropharyngeal carcinoma: final analysis of a </span>
<span id="tm_214" class="t s4_214">randomized trial of the EORTC cooperative group of radiotherapy. </span>
<span id="tn_214" class="t s4_214">Radiother Oncol 1992;25:231-241. Available at: </span>
<span id="to_214" class="t s5_214">http://www.ncbi.nlm.nih.gov/pubmed/1480768</span><span id="tp_214" class="t s4_214">. </span>
<span id="tq_214" class="t s4_214">167. Horiot JC. [Controlled clinical trials of hyperfractionated and </span>
<span id="tr_214" class="t s4_214">accelerated radiotherapy in otorhinolaryngologic cancers]. Bull Acad Natl </span>
<span id="ts_214" class="t s4_214">Med 1998;182:1247-1260; discussion 1261. Available at: </span>
<span id="tt_214" class="t s5_214">http://www.ncbi.nlm.nih.gov/pubmed/9812410</span><span id="tu_214" class="t s4_214">. </span>
<span id="tv_214" class="t s4_214">168. Horiot JC, Bontemps P, van den Bogaert W, et al. Accelerated </span>
<span id="tw_214" class="t s4_214">fractionation (AF) compared to conventional fractionation (CF) improves </span>
<span id="tx_214" class="t s4_214">loco-regional control in the radiotherapy of advanced head and neck </span>
<span id="ty_214" class="t s4_214">cancers: results of the EORTC 22851 randomized trial. Radiother Oncol </span>
<span id="tz_214" class="t s4_214">1997;44:111-121. Available at: </span>
<span id="t10_214" class="t s5_214">http://www.ncbi.nlm.nih.gov/pubmed/9288839</span><span id="t11_214" class="t s4_214">. </span>
<span id="t12_214" class="t s4_214">169. Konski AA, Winter K, Cole BF, et al. Quality-adjusted survival </span>
<span id="t13_214" class="t s4_214">analysis of Radiation Therapy Oncology Group (RTOG) 90-03: phase III </span>
<span id="t14_214" class="t s4_214">randomized study comparing altered fractionation to standard fractionation </span>
<span id="t15_214" class="t s4_214">radiotherapy for locally advanced head and neck squamous cell </span>
<span id="t16_214" class="t s4_214">carcinoma. Head Neck 2009;31:207-212. Available at: </span>
<span id="t17_214" class="t s5_214">http://www.ncbi.nlm.nih.gov/pubmed/19107946</span><span id="t18_214" class="t s4_214">. </span>
<span id="t19_214" class="t s4_214">170. Bourhis J, Overgaard J, Audry H, et al. Hyperfractionated or </span>
<span id="t1a_214" class="t s4_214">accelerated radiotherapy in head and neck cancer: a meta-analysis. </span>
<span id="t1b_214" class="t s4_214">Lancet 2006;368:843-854. Available at: </span>
<span id="t1c_214" class="t s5_214">http://www.ncbi.nlm.nih.gov/pubmed/16950362</span><span id="t1d_214" class="t s4_214">. </span>
<span id="t1e_214" class="t s4_214">171. Baujat B, Bourhis J, Blanchard P, et al. Hyperfractionated or </span>
<span id="t1f_214" class="t s4_214">accelerated radiotherapy for head and neck cancer. Cochrane Database </span>
<span id="t1g_214" class="t s4_214">Syst Rev 2010;12:CD002026. Available at: </span>
<span id="t1h_214" class="t s5_214">http://www.ncbi.nlm.nih.gov/pubmed/21154350</span><span id="t1i_214" class="t s4_214">. </span>
<span id="t1j_214" class="t s4_214">172. Lacas B, Bourhis J, Overgaard J, et al. Role of radiotherapy </span>
<span id="t1k_214" class="t s4_214">fractionation in head and neck cancers (MARCH): an updated meta- </span>
<span id="t1l_214" class="t s4_214">analysis. Lancet Oncol 2017;18:1221-1237. Available at: </span>
<span id="t1m_214" class="t s5_214">https://www.ncbi.nlm.nih.gov/pubmed/28757375</span><span id="t1n_214" class="t s4_214">. </span>
<span id="t1o_214" class="t s4_214">173. Budach V, Stuschke M, Budach W, et al. Hyperfractionated </span>
<span id="t1p_214" class="t s4_214">accelerated chemoradiation with concurrent fluorouracil-mitomycin is more </span>
<span id="t1q_214" class="t s4_214">effective than dose-escalated hyperfractionated accelerated radiation </span>
<span id="t1r_214" class="t s4_214">therapy alone in locally advanced head and neck cancer: final results of </span>
<span id="t1s_214" class="t s4_214">the radiotherapy cooperative clinical trials group of the German Cancer </span>
<span id="t1t_214" class="t s4_214">Society 95-06 Prospective Randomized Trial. J Clin Oncol 2005;23:1125- </span>
<span id="t1u_214" class="t s4_214">1135. Available at: </span><span id="t1v_214" class="t s5_214">http://www.ncbi.nlm.nih.gov/pubmed/15718308</span><span id="t1w_214" class="t s4_214">. </span>
<span id="t1x_214" class="t s4_214">174. Budach W, Hehr T, Budach V, et al. A meta-analysis of </span>
<span id="t1y_214" class="t s4_214">hyperfractionated and accelerated radiotherapy and combined </span>
<span id="t1z_214" class="t s4_214">chemotherapy and radiotherapy regimens in unresected locally advanced </span>
<span id="t20_214" class="t s4_214">squamous cell carcinoma of the head and neck. BMC Cancer 2006;6:28. </span>
<span id="t21_214" class="t s4_214">Available at: </span><span id="t22_214" class="t s5_214">http://www.ncbi.nlm.nih.gov/pubmed/16448551</span><span id="t23_214" class="t s4_214">. </span>
<span id="t24_214" class="t s4_214">175. Bensadoun R-J, Benezery K, Dassonville O, et al. French multicenter </span>
<span id="t25_214" class="t s4_214">phase III randomized study testing concurrent twice-a-day radiotherapy </span>
<span id="t26_214" class="t s4_214">and cisplatin/5-fluorouracil chemotherapy (BiRCF) in unresectable </span>
<span id="t27_214" class="t s4_214">pharyngeal carcinoma: Results at 2 years (FNCLCC-GORTEC). Int J </span>
<span id="t28_214" class="t s4_214">Radiat Oncol Biol Phys 2006;64:983-994. Available at: </span>
<span id="t29_214" class="t s5_214">http://www.ncbi.nlm.nih.gov/pubmed/16376489</span><span id="t2a_214" class="t s4_214">. </span>
<span id="t2b_214" class="t s4_214">176. Budach V, Stromberger C, Poettgen C, et al. Hyperfractionated </span>
<span id="t2c_214" class="t s4_214">accelerated radiation therapy (HART) of 70.6 Gy with concurrent 5- </span>
<span id="t2d_214" class="t s4_214">FU/Mitomycin C is superior to HART of 77.6 Gy alone in locally advanced </span>
<span id="t2e_214" class="t s4_214">head and neck cancer: long-term results of the ARO 95-06 randomized </span>
<span id="t2f_214" class="t s4_214">phase III trial. Int J Radiat Oncol Biol Phys 2015;91:916-924. Available at: </span>
<span id="t2g_214" class="t s5_214">https://www.ncbi.nlm.nih.gov/pubmed/25670541</span><span id="t2h_214" class="t s4_214">. </span>
<span id="t2i_214" class="t s6_214">Printed by Fredd Merc on 8/29/2024 4:45:54 AM. For personal use only. Not approved for distribution. Copyright © 2024 National Comprehensive Cancer Network, Inc., All Rights Reserved. </span></div>

</div>
</body>
</html>
